Which channels produced treated, paying patients?

Most pain practices know referral matters and cannot say which referrers produce revenue rather than consultations, or whether that changed this year.

Referred patients added to the lead file, tagged with the referring physician, rank referrers on treatment revenue alongside paid channels — which is both a marketing report and a relationship-management one.

A patient may attend for a series of injections over months. Attributing only the first visit undercounts the channel that produced them several times over.

Matching on the patient means the whole episode credits the original channel, which is the only figure that can sensibly be compared against acquisition cost.

Between the consultation and the interventional procedure sits an approval process that takes days in a good case and several weeks in an ordinary one. Some of those requests are declined, some are approved for a lesser procedure, and some expire while paperwork moves between offices. None of this is visible to an advertising platform, which recorded a conversion when the appointment was booked and closed the file. The practice, meanwhile, has spent clinical time and administrative hours on a patient who may never reach the schedule at all, and the advert that produced them still looks successful in every report anybody reads.

The rate at which that gate opens is not constant across sources, and that is the part that makes it a marketing problem rather than a billing one. Campaigns written around coverage attract patients for whom coverage is the deciding question, and their plans differ systematically from those of patients arriving through a physician who has already considered what will be approved. Two campaigns with identical consultation volumes can therefore produce very different procedure volumes, and a practice ranking on consultations will fund the weaker one indefinitely without anything appearing to be wrong.

Uploading the consultation list alongside the collected-procedure list turns that into a ratio per source, with no modeling and no assumptions about what should have been approved. Practices that look at it rarely switch the weaker campaign off. They move the qualifying questions earlier, change what the landing page promises, or route those inquiries to a different part of the practice, because the demand was real and the filtering was simply happening after the expensive part of the process rather than before it.

A practice treating injured workers and accident cases is operating two payment models at once. Commercial visits settle within weeks at a contracted rate. A compensation case is authorized case by case, paid on a state fee schedule, and may be contested along the way; a liability case may not pay anything at all until the underlying claim resolves, which can take two or three years. Advertising that produces those cases is therefore assessed, if it is assessed at all, on a timescale no marketing report is built to accommodate.

What practices do in response is understandable and wrong: they leave the whole line out of the channel comparison because the timing is awkward, and then wonder why the paid media numbers never quite reconcile with the practice's actual income. The campaigns producing compensation and accident work go unexamined for years, which is a substantial amount of money to spend on instinct, and the campaigns producing commercial visits are held to a standard the others are excused from. The result is a practice with a rigorous view of its least valuable caseload and no view at all of the one that takes three years to pay.

This reconciliation is indifferent to the delay. A payment arriving in 2028 against an inquiry from 2026 joins on the patient's contact details exactly as a same-week payment would, because there is no window and no session involved. Running the report over a completed multi-year range therefore answers the question properly, without a payer-type column, which would be health information and does not belong in the file. Reading a three-year liability settlement as though it were monthly commercial revenue misleads about both.

Marketing in this field is written around what patients search for: back pain, neuropathy, sciatica, headaches. Revenue arrives as something else entirely — an injection series, a radiofrequency procedure, a trial and an implant, or a sequence of medication management visits worth a fraction of any of those. The two vocabularies never meet. A campaign targeting one condition may produce patients who mostly end up on the procedural pathway while another produces patients who are managed conservatively for a year, and both campaigns look the same in an account measured on new patient volume.

The gap between those pathways is not marginal. A single procedure can be worth what twenty office visits are worth, so a source producing a modest number of procedural patients can outrank a source producing three times the headcount, and will do so consistently. Practices that have never ranked on money have no way of knowing which of their campaigns is which, and the natural tendency is to favor whichever one produces more appointments, because appointments are the thing that can be counted on a Monday morning.

Reading revenue per sale beside each channel closes part of the gap: a campaign built to recruit procedural candidates shows fewer, larger sales than one filling routine visits, so it is not judged on total headcount alone. A service-line column would label the split, but the treatment somebody received is health information, and CloseRev signs no business associate agreements, so it stays out of the export. The ranking can still settle a recurring internal argument about which condition to advertise next, because the answer stops being a matter of who in the practice feels most strongly and becomes a matter of what the last twelve months produced.